You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes

Alerts

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address